Lenneke J. M. Brouwer
Papers
1
Total Citations
3
H-Index
1
About
Lenneke J. M. Brouwer is a leading researcher in molecular imaging and prostate cancer diagnostics, with a focus on validating novel PET/CT tracers for clinical application. Her key research areas include prostate-specific membrane antigen (PSMA) imaging, immunohistochemical validation, and histopathological correlation of radiotracers. Brouwer’s major contribution lies in the rigorous validation of ¹⁸F‑PSMA‑1007 PET/CT for detecting intraprostatic cancerous lesions, bridging the gap between imaging findings and tissue-level pathology. Her landmark 2023 study, which has garnered 3 citations, provides critical evidence that PSMA‑targeted PET/CT can accurately identify tumor foci within the prostate, offering a non‑invasive alternative to systematic biopsies. This work has significant implications for guiding focal therapy and improving risk stratification in prostate cancer patients. Brouwer’s research is notable for its methodological rigor, combining advanced immunohistochemistry with histopathological analysis to confirm tracer uptake patterns. Her findings are already influencing clinical protocols and shaping the next generation of precision diagnostics in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1